Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
出版年份 2020 全文链接
标题
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-28
DOI
10.1038/s41467-020-14906-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis
- (2019) Xiang Yu et al. Nature Communications
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
- (2018) Antoni Ribas et al. CELL
- Biomaterial-assisted targeted modulation of immune cells in cancer treatment
- (2018) Hua Wang et al. NATURE MATERIALS
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
- (2018) Zuqiang Liu et al. Nature Communications
- The Current State of Peptide Drug Discovery: Back to the Future?
- (2017) Antoine Henninot et al. JOURNAL OF MEDICINAL CHEMISTRY
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
- (2017) Manisha Singh et al. Nature Communications
- Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
- (2017) Zuqiang Liu et al. Nature Communications
- Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy
- (2016) Mingjun Liu et al. Journal of Translational Medicine
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+T cells
- (2016) Shu Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vivo Visualization of Tumor Antigen-containing Microparticles Generated in Fluorescent-protein-elicited Immunity
- (2016) Fei Yang et al. Theranostics
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity
- (2015) Natalie L. Trevaskis et al. NATURE REVIEWS DRUG DISCOVERY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- The role of lymph node sinus macrophages in host defense
- (2014) Mirela Kuka et al. Annals of the New York Academy of Sciences
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Hybrid Melittin Cytolytic Peptide-Driven Ultrasmall Lipid Nanoparticles Block Melanoma Growth in Vivo
- (2013) Chuan Huang et al. ACS Nano
- Melittin: A lytic peptide with anticancer properties
- (2013) Goran Gajski et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Bee Venom Phospholipase A2 Induces a Primary Type 2 Response that Is Dependent on the Receptor ST2 and Confers Protective Immunity
- (2013) Noah W. Palm et al. IMMUNITY
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Engineering synthetic vaccines using cues from natural immunity
- (2013) Darrell J. Irvine et al. NATURE MATERIALS
- Role of the inflammasome in defense against venoms
- (2013) N. W. Palm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
- (2012) Jose Pulido et al. NATURE BIOTECHNOLOGY
- Whole Cell Vaccines—Past Progress and Future Strategies
- (2012) Bridget P. Keenan et al. SEMINARS IN ONCOLOGY
- Bee venom in cancer therapy
- (2011) Nada Oršolić CANCER AND METASTASIS REVIEWS
- Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
- (2009) Zhihong Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
- (2009) Neelesh R. Soman et al. JOURNAL OF CLINICAL INVESTIGATION
- Materials engineering for immunomodulation
- (2009) Jeffrey A. Hubbell et al. NATURE
- Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
- (2009) Manuel N. Melo et al. NATURE REVIEWS MICROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started